Open-access Vacunación contra hepatitis B

Vaccination against HBV

Resúmenes

La prevención de la infección por virus B se basa en medidas generales como tamizaje de hemoderivados, prácticas sexuales seguras y uso de jeringas desechables. La inmunización activa es la estrategia más importante para evitar la infección y sus complicaciones. La inmunización pasiva es útil para prevenir la infección en situaciones especiales.

hepatitis B; inmunización


The prevention of the infection by virus B is based on general measures such as screening of hemoderivatives, safe sex practices and use of disponsable syringes. Active immunization is the most important strategy to avoid the infection and its complications. Passive immunization is used to prevent the infection in special situations.

hepatitis B; immunization


*+

Descriptores

Lecturas

Referencias bibliográficas

  • Davis J. Experience with hepatitis A and B vaccines. Am J Med 2005; 118(10 A): 7s-15s.

  • Centers For Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United Statesthrough universal childhood vaccination. Recommendations of the Inmunization Practices Advisory Committee (ACIP). MMWR RecommRep 40 (1991) (RR-13); 1-19.

  • Centers for Disease Control. Notice to readers update recommendations to prevent hepatitis B transmission-United States. MMWR MorbMortal Wkly Rep. 1995; 574-575.

  • Centers for Disease Control and Prevention. Notice to readers update recommendations to prevent Hepatitis B virus transmission-United States, MMWR MorbWkly Rep.1999:48; 33-34.

  • Poland G. Evaluating existing recommendations for hepatitis A and B vaccination. AmJ Med. 2005; 118: 16s-20s.

  • Mc Mahon BJ, Bruden DL. Antibody levels and protection after hepatitis B vaccination; results of a 15 year follow-up. Ann Intern Med. 2005; 142: 333-341.

  • European Consensus Group on Hepatitis B Inmunity. Are booster immunizations needed for lifelong hepatitis B immunity?. Lancet 2000; 355: 561-65.

  • Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, Coppola RC, et al. Long term inmunogenicityof hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366(9494): 1379-84.

  • C Lee, YGong, J Brok, EH Boxall, C Gluudl. Hepatitis B immunization for newborn infants of hepatitis B surface antigen positive mothers. Cochrane Database SystRev. 2006 19; CD004790.

  • Poland GA, Jacobson Rm. Prevention of Hepatitis B with the hepatitis B vaccine. N EnglJ Med. 2004; 351: 2832-8.

  • Aggarwal R, RanjanP. Preventing and treating Hepatitis B infection. BMJ 2004; 329: 1080-6.



*Gastroenterólogo. Hospital de San Carlos

Fechas de Publicación

  • Publicación en esta colección
    12 Nov 2015
  • Fecha del número
    Nov 2008
Creative Common -
location_on
Colegio de Médicos y Cirujanos de Costa Rica Apdo. 548-1000, Sabana Sur, San José, Costa Rica, San José, San José, CR, 504-1000, 2210-2200, 22102279 - E-mail: actamedica@medicos.cr
rss_feed Acompanhe os números deste periódico no seu leitor de RSS
Acessibilidade / Reportar erro